Introduction {#sec1}
============

Ischemic stroke, which is the most common type of stroke, is a great challenge for contemporary medicine. It poses both diagnostic and therapeutic difficulties.

Advances in the treatment of ischemic strokes have offered patients a greater chance for recovery and return to normal life. That is why early diagnosis and identification of pathological conditions that might lead to this outcome are of particular importance.

Each year, 15 million cases of ischemic stroke are noted worldwide (214 cases per 100,000 inhabitants)^([@bib1])^. In Poland, there are about 70,000 cases annually, 30,000 of which are fatal. A snowball increase is noted in the number of cerebrovascular accidents (CVAs), ranging from transient ischemic accidents (TIA) to ischemic strokes. This increase is estimated at 1.9% per year and is clearly linked with ageing society.

Atherosclerosis: a new paradigm in diagnosis {#sec2}
============================================

The fundamental and one of the main causes of CVAs is atherosclerosis, a disease which is beginning to affect more and more social groups. Atherosclerosis is currently defined as a generalized, dynamic and heterogeneous inflammatory and immune process that involves arterial walls. It may lead to blood flow obstruction in the affected vessel, which entails the occurrence of certain defined clinical signs and symptoms. A structure called *atherosclerotic plaque* is central to the disorders induced by atherosclerosis^([@bib2])^ (Fig. [1](#fig1){ref-type="fig"}).

![Atherosclerotic plaque: a schematic](jou-20-81-e135-g001){#fig1}

In accordance with the Mannheim consensus^([@bib3]--[@bib6])^ published in 2007 and later revised, atherosclerotic plaque is defined as a focal structure that builds up into the arterial lumen to at least 0.5 mm or 50% of the surrounding intima-media thickness. The ability to evaluate plaque formation dynamics and its complications (including rupture and displacement) is a very important and not yet well-explored problem. Most patients with atherosclerotic plaque present no signs of vascular disorders, which means that most plaques are silent and asymptomatic.

Disorders do appear only with hemodynamically significant stenosis or vascular occlusion and blood flow obstruction or blockage. These changes occur during the natural development of atherosclerosis that leads to the formation or development of changes within the plaque itself, such as its enlargement or mineral remodeling,^([@bib7])^ as well as changes within its lipid core and on its surface (so-called *fibrous cap*)^([@bib8])^.

In light of contemporary studies, the paradigm of the relationship of atherosclerosis and CVAs has changed as there are also plaques of vast damage potential that do not cause vascular stenoses or occlusion by their sole presence, but since they are capable of initiating a cascade leading to the formation and activation of plaque-related clots, they may cause ischemic strokes that in consequence result in sudden death^([@bib9])^. Owing to this potential, these plaques are called unstable or "vulnerable"^([@bib10],[@bib11])^.

The main problem in atherosclerotic plaque imaging is to identify the moment of potential transformation of a stable plaque into vulnerable plaque. The identification of a precise time of plaque destabilization defines the moment of proper treatment initiation, whether it be conservative treatment (anti-aggregation therapy, statins, cilostazol and other phosphodiesterase 3 inhibitors, peroxisome proliferator-activated receptors (PPAR) and their agonists, metalloproteinase inhibitors) or a surgical procedure (endarterectomy, endovascular procedures and sonothrombolysis or ultrasound-accelerated thrombolysis enhanced with contrast agents).

Vulnerable plaque as a diagnostic target {#sec3}
========================================

In patients at risk of cerebral ischemia, a site that is both crucial for the build-up of pathologic changes and convenient for clinical assessment is the carotid artery, a vessel representative for the evaluation of atherosclerosis progression.

The detection of features indicating active inflammation within atherosclerotic plaque, based on neovascularization within the lipid core structures or monitoring the levels of inflammatory products, is a criterion of certain atherosclerotic plaque instability^([@bib12],[@bib13])^.

Definition of vulnerable plaque {#sec4}
===============================

The density of neovascular network within atherosclerotic plaque correlates with the stage of atherosclerosis^([@bib14])^. These vessels are believed to be the primary cause of complications in the development of atherosclerotic plaque as they are a site of bleeding or inflammation and may in consequence lead to the loss of plaque stability. The degree of their "maturity" is proportional to a decrease in plaque stability as they are more susceptible to damage, and therefore also to blood extravasation to the plaque, formation of microthrombi and abrupt plaque enlargement^([@bib15],[@bib16])^.

The plaque transforms from stable plaque into plaque with thin fibrous cap atheroma/thin cap atheromatic plaque, (TFCA/TCAP) and finally into unstable or vulnerable plaque^([@bib11],[@bib17])^ (Fig. [2](#fig2){ref-type="fig"}).

![Atherosclerotic plaque evolution into vulnerable plaque (Virmani^34^)](jou-20-81-e135-g002){#fig2}

In the case of fibrous cap rupture, when the lipid core is damaged and there is potential bleeding into the plaque, the material is released into the vascular lumen, which might lead to vascular occlusion and a CVA^([@bib16],[@bib18])^.

It is then currently crucial to properly identify plaque instability within the carotid arteries by evaluating parameters and phenomena that signify an initiating cascade of complications eventually leading to stroke.

The evaluation of atherosclerotic plaque should then include:

-   fibrous cap thickness;

-   size of the lipid necrotic core;

-   identification of plaque neovascularization;

-   identification of the direction of plaque remodeling;

-   detection of fibrous cap damage or risk of its occurrence.

Ultrasonography is the most available, the cheapest and noninvasive method of examining arteries to identify and assess the morphology and condition of atherosclerotic plaque. Within the past 20 years, two-dimensional ultrasound (2D, B-Mode) and Doppler imaging have become the mainstay of assessment of pre-cranial carotid artery segments. These modalities enable the evaluation of both vascular morphology and blood flow dynamics, including: flow direction, velocity, volume, laminar flow or pressure gradient.

Ultrasonographic methods of atherosclerotic plaque evaluation {#sec5}
=============================================================

Atherosclerotic plaques can be examined using several ultrasound-based techniques, including:

-   real-time ultrasound (B-Mode, 2D Mode);

-   Doppler ultrasound: color flow mode, power Doppler (in various configurations), including directional power Doppler, superb microvascular imaging;

-   non-Doppler flow evaluation methods (B-Flow);

-   spatial (volumetric) ultrasound;

-   contrast-enhanced ultrasound (CEUS);

-   shear wave elastography (SWE).

The three last techniques (i.e. volumetric ultrasound, CEUS and elastography) will be discussed in the next parts of this publication series.

Types of atherosclerotic plaque {#sec6}
===============================

The echogenicity of atherosclerotic plaque mainly depends on lipids in its core and necrotic elements of the lipid core as well as on core microvascularization^([@bib15],[@bib19]--[@bib21])^ and mineralized or fibrous components.

In order to introduce uniform terminology regarding atherosclerotic plaque types, an ultrasound-based classification, called Gray-Weale--Nicolaides (GWN) classification^([@bib22],[@bib23])^, has been introduced. It is based on the subjective image of plaque---its echogenicity---on B-Mode (2D) images. This classification distinguishes between five types (classes) of plaque, as described below.

Type (class) I: uniformly echolucent plaque {#sec7}
===========================================

Plaque is almost entirely "translucent". It is homogeneous, hypoechoic and composed mainly of lipid elements and necrotic structures (Fig. [3](#fig3){ref-type="fig"}).

![*Uniformly echolucent plaque on the posterior wall of the LCCA (left common carotid artery)*. **A.** *B-Mode*. **B.** *CFM mode. Author's own material*](jou-20-81-e135-g003){#fig3}

When imaging this type of plaque, attention must be paid to the presence and echogenicity of the fibrous cap. The hypoechoic structure of the plaque, similar to the echogenicity of fluid, is the primary difficulty. The level of echogenicity depends on the relationship between lipid--necrotic elements and fibrous structures of the plaque matrix.

The plaque border is visualized using Doppler imaging (Fig. [4](#fig4){ref-type="fig"} and Fig. [5](#fig5){ref-type="fig"}) or non-Doppler methods (B-Flow), and the visualization depends on the image of blood flow in the vessel. The detection of a thin fibrous cap defines the plaque as TCAP (thin cap atheromatic plaque) and places it in the category of vulnerable plaques. It must be noted, however, that the fibrous cap with the thickness that defines it as TCAP is not visible on classical ultrasound, and its evaluation is highly subjective.

![*Uniformly echolucent plaque on the posterior wall of the ICA (internal carotid artery)*. **A.** *Plaque is visible thanks to flow visualization in a directional power Doppler examination*. **B.** *Plaque visualized in a volumetric examination. Author's own material*](jou-20-81-e135-g004){#fig4}

![Type (class) II plaque on the posterior wall of the CCA bifurcation. Author's own material](jou-20-81-e135-g005){#fig5}

To sum up, type I plaques in the GWN classification are indistinguishable from fluid inside the vessel as seen on a B-Mode image due to their low echogenicity. They may be therefore overlooked in a diagnostic test. That is why most plaques are classified as type II plaques.

Type (class) II: predominately echolucent plaque {#sec8}
================================================

The plaque composition is as in type I with additional presence of single calcifications which perfectly aid in plaque imaging but prevent the precise visualization of the fibrous cap border due to reverberation at the calcification edges on a B-Mode image. The calcified part of the plaque should not exceed 25% of the plaque volume (in a volumetric examination) or 20--25% of the plaque size (in 2D assessment) (Fig. [5](#fig5){ref-type="fig"}, Fig. [6](#fig6){ref-type="fig"}, Fig. [7](#fig7){ref-type="fig"}).

![*Atherosclerotic plaque on the ICA anterior wall*. **A.** *Type II plaque, TCAP with elements of JBA (juxtaluminal black area) -- blue arrow, and calcification -- red arrow*. **B.** *Plaque visualized in a volumetric examination. Author's own material*](jou-20-81-e135-g006){#fig6}

![*Mixed type II plaque*. **A.** *On the posterior wall of the CCA bifurcation, CFM image*. **B.** *On the ICA posterior wall -- SMI (superb microvascular imaging). Author's own material*](jou-20-81-e135-g007){#fig7}

Type (class) III: predominantly echogenic plaque {#sec9}
================================================

Plaque composition is as in type II with numerous calcifications constituting up to 50% of the plaque structure (Fig. [8](#fig8){ref-type="fig"}).

![Heterogeneous type III plaque. Authors' own material](jou-20-81-e135-g008){#fig8}

Numerous reverberations at the calcification edges make the visualization of the borders and course of the fibrous cap extremely difficult on a B-Mode image. Plaque evaluation and its potential classification as TCAP is dubious due to relatively numerous reverberations associated with the presence of mineralized components.

In this group of plaques, flow imaging with Doppler or non-Doppler methods facilitates classification of plaque surface defects and enables visualization of potential irregularities and ulcerations.

Type (class) IV: uniformly echogenic plaque {#sec10}
===========================================

Plaque composition is as in type II with numerous calcifications constituting over 50% of the plaque structure (Fig. [9](#fig9){ref-type="fig"}).

![Type IV plaque; ICA flow with visible contrast enhancement. Authors' own material](jou-20-81-e135-g009){#fig9}

Difficulties are similar to those in type III plaques with a significant increase in the number of reverberations.

The classification of plaques to type IV is difficult based on subjective assessment because of potential irregular distribution of echogenic areas that prevent imaging.

Type (class) V: heavy calcification {#sec11}
===================================

In this case, the evaluation of echogenicity, which in practice means the number of calcifications, is impossible on B-Mode and Doppler imaging.

Any attempts to assess plaque surface in this type of plaque are feasible only with specialized techniques: STIC B-Flow (spatiotemporal image correlation using the B-Flow technique) (Fig. [10](#fig10){ref-type="fig"} B), CEUS (Fig. [10](#fig10){ref-type="fig"} C) and possibly also intravascular ultrasound (IVUS) as well as volumetric ultrasound. Numerous reverberations prohibit plaque structure assessment and evaluation of the borders of its individual elements. Fibrous cap imaging in type V plaques is almost infeasible (Fig. [10](#fig10){ref-type="fig"}).

![*Completely calcified plaque*. **A.** *Acoustic shadow covers the field of view;* **B.** *B-Flow STIC imaging*. **C.** *CEUS. Author's own material*](jou-20-81-e135-g010){#fig10}

The visualization of the arterial wall of pre-cranial arteries is an integral part of an ultrasound examination. This includes wall structure assessment with the measurement of the intima-media (IM) thickness, i.e. the total thickness of the tunica intima and tunica media. This measure is abbreviated as IMT. The IM complex is described^([@bib24])^ as a linear structure visible on both arterial walls (CCA, ICA, ECA) that can be imaged simultaneously in the longitudinal view. On ultrasound, it presents as a linear echogenic region that begins at the border of the vividly hypoechoic vascular lumen and reaches the hypoechoic linear area between the adventitia and tunica media. In physiological conditions, the intima-media thickness ranges from 0.5 to 0.9 mm^([@bib10],[@bib11],[@bib25])^ (Fig. [11](#fig11){ref-type="fig"}).

![*Measurements*. **A.** *IMT;* **B.** *VWT. Author's own material*](jou-20-81-e135-g011){#fig11}

IMT is assessed by taking measurements in strictly specified points in individual arteries and then by calculating the average value (in proximal, medial and distal segments of the CCA and ICA and in the CCA bifurcation as well as, if needed, in the ECA and, when high-end ultrasound equipment is available, also in the vertebral artery). Alternatively, IMT can be calculated in the examined segment of the artery using an IMT-dedicated tool integrated with the ultrasound calculation software (Fig. [12](#fig12){ref-type="fig"} A).

![*Plaque ulceration*. **A.** *CFM image*. **B.** *SMI*. **C.** *Volumetric examination -- surface rendering. Authors' own material*](jou-20-81-e135-g012){#fig12}

In normal conditions, when there is no atherosclerotic plaque, the arterial wall is clearly visible on a 2D (B-Mode) examination.

In multicenter ECST (European Carotid Surgery Trial) and NASCET (North American Symptomatic Carotid Endarerectomy Trial) trials^([@bib7])^, whose goal was to establish the eligibility of patients to endarterectomy (the criterion of plaque stability was not taken into account in these trials), the fundamental parameters defining the atherosclerotic plaque were, next to IMT: the direction of plaque modeling and the total plaque size expressed as VWT (vessel wall thickness). This parameter is used to monitor treatment effects and assess the size of atherosclerotic plaque. It is also used when IMT is over 2 mm^([@bib26])^ (Fig. [11](#fig11){ref-type="fig"} B).

The term VWT^([@bib7],[@bib27])^ was first used in studies on atherosclerotic plaques at the time when a vessel was considered a rigid "pipe," where flow was evaluated as only a physical image of fluid rheological changes with no consideration devoted to dynamic changes in the walls of the described "pipe" and without taking into account any oscillation disorders or laminar flow. The wall thickness was the only parameter measured, and only when the value was significantly increased was the change described as atherosclerotic plaque.

In the 1970s, a relationship was found between the presence of defects on the surface of atherosclerotic plaque (irregularities, fissures, ulcerations) and CVAs (Clark, Koch, Constantinides)^([@bib28],[@bib29])^. It was concluded that the presence of changes (irregularity or ulceration) on the plaque surface indicates potential plaque instability and its greater susceptibility to damage (vulnerable plaque)^([@bib30])^. It was also stated that the presence of ulceration on the plaque surface is linked with the development of necrotic changes in the plaque lipid core that cause deformity and damage of the fibrous cap, which in turn leads to the transformation of stable plaque into vulnerable plaque^([@bib31])^.

In most of the available literature, authors mention difficulties linked with adequate assessment of defects on the surface of vascular endothelium (continuity defects). They prohibits the visualization of laminar blood flow directly adjacent to plaque structures. Laminar flow disorders cause thrombocyte adhesion at the site of the endothelial defect, thus initiating a cascade of pathologies leading to CVA.

In accordance with contemporary statements^([@bib32]--[@bib35])^, plaque surface irregularity should be distinguished from its ulceration. Ulceration is defined as a defect on the plaque surface measuring at least 2×2 mm and reaching the nearest visible IM complex. Smaller defects should be treated as irregularities, which are changes of lower clinical relevance.

Ulceration, i.e. plaque erosion, is described as an "acute," abruptly developing thrombus, found directly adjacent to the intima media in the vessel wall with no endothelium^([@bib16],[@bib18],[@bib36])^ (Fig. [12](#fig12){ref-type="fig"}).

On ultrasound, this form of lesion presents as a hypoechoic intrusion on the plaque surface; its echogenicity depends on the size of the "fresh" thrombotic component. With thrombocytes being predominant, this component appears clearly hypoechoic. The image becomes slightly less hypoechoic when there are more collagen fibers making up the clot matrix; it may even appear iso-/normoechogenic in relation to the remaining plaque structures. The image can be echogenic when fibrous elements prevail. This structure is defined by some authors^([@bib19],[@bib37],[@bib38])^ as JBA (juxtaluminal black area) or JHA (juxtaluminal hypoechoic area) (Fig. [7](#fig7){ref-type="fig"})^([@bib39],[@bib40])^.

As for ulceration, its atypical position in relation to atherosclerotic plaque, usually at the margin of the plaque, and the presence of marginal calcification at the edges of ulceration, are characteristic features^([@bib41]--[@bib43])^ (Fig. [13](#fig13){ref-type="fig"}).

![Atherosclerotic plaque with smooth surface GWN IIIa. Authors' own material](jou-20-81-e135-g013){#fig13}

Plaque ulceration is a much more frequent cause of thrombi than plaque rupture (74% of cases: ulceration and its complications; 40% of cases: rupture and its complications)^([@bib11])^. Attention must be paid to the fact that plaque ulceration and its complications are considered a cause of approximately 20% of sudden deaths from cerebrovascular accidents and cardiovascular events.

The ultrasound appearance of plaque surface (irregularity or ulceration) helps identify its instability. This way, it supplements the description of plaque echogenicity in the Gray-Weale--Nicolaides classification, and is described with letters as:

-   A -- smooth plaque (Fig. [13](#fig13){ref-type="fig"});

-   B -- irregular plaque (Fig. [14](#fig14){ref-type="fig"});

-   C -- ulcerated plaque (Fig. [15](#fig15){ref-type="fig"}).

![Atherosclerotic plaque with irregular surface GWN IIIb. Authors' own material](jou-20-81-e135-g014){#fig14}

![Atherosclerotic plaque with ulceration GWN IIIc. Authors' own material](jou-20-81-e135-g015){#fig15}

For instance, the plaque from Fig. [16](#fig16){ref-type="fig"} with calcification of over 50% of the plaque volume and with the irregular surface should be described as type IIIb plaque in the Gray-Weale--Nikolaides classification.

![Type IIIb plaque in the Gray-Weale--Nikolaides classification. Authors' own material](jou-20-81-e135-g016){#fig16}

Conclusion {#sec12}
==========

Irrespective of the ultrasound technique employed, proper morphological evaluation of atherosclerotic plaque by means of subjective observation of echogenicity with classification to Gray-Weale--Nicolaides types as well as assessment of the integrity of plaque surface, makes it possible to roughly evaluate plaque morphology and thereby its stability.

The contemporary techniques make this classification more objective. Computer software enables assessment and measurement of the plaque with the calculation of mean percentage values regarding the size of echogenic zones that correspond with plaque containing a greater number of fibrous or calcified structures.

Moreover, other ultrasound-based plaque classifications are appearing, taking into account both individual images of the plaque surface and plaque echogenicity. However, they are all derived from the original GWN classification^([@bib44])^.

The subjective assessment (visual scoring) should therefore be supplemented with the grey-scale median (GSM) evaluation, representing median tonal distribution of pixels in a scale from 0 (black) to 255 (white). On ultrasound, fluid (blood) corresponds with the lowest values, ranging from 0 to 5 in the GSM, while the highest values, from 180 to 200 in the GSM, represent solid tissues (adventitia)^([@bib18],[@bib24],[@bib45])^. Assigning the values to the observed parts of the plaque should be performed using as broad region of interest (ROI) as possible, i.e. the largest possible region encompassing the examined structure as allowed by the transducer.

Attention should be paid to the need for further, multidirectional diagnosis of atherosclerotic plaque in high-risk patients, including volumetric (spatial) imaging examinations^([@bib8],[@bib11],[@bib20])^, contrast-enhanced ultrasound^([@bib14],[@bib46]--[@bib49])^ (Fig. [17](#fig17){ref-type="fig"}) or strain and shear wave elastography^([@bib50],[@bib51])^ (Fig. [18](#fig18){ref-type="fig"}).

![Atherosclerotic plaque, CEUS. Authors' own material](jou-20-81-e135-g017){#fig17}

![Atherosclerotic plaque, SWE. Authors' own material](jou-20-81-e135-g018){#fig18}
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